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Sir,
We have read with interest the recent paper in the British
Journal of Cancer (Wang et al, 2003). Our groups have worked on
TIMP-1 gene regulation for a number of years, including a
dissection of the gene promoter in both human and mouse.
The 18bp HTE-1 enhancer element used in this paper (and
others referenced therein) is described to be in intron 1 of the
human TIMP-1 gene. However, a search of sequences from our
own human and mouse TIMP-1 genomic clones, or indeed a
BLAST into the human genomic sequence databases, including the
X-chromosome sequences containing the TIMP-1 gene, do not
reveal a perfect match for HTE-1. The best match in the human
genome, for the first 16 base pairs of HTE-1, is in chromosome 17
(though outside of the TIMP-2 gene which lies on this chromo-
some). It is with some concern that we note that the HTE-1
sequence is matched in its entirety within the E. coli genome.
The authors have cloned an IL-10-responsive DNA-binding
protein on the basis of its binding to the HTE-1 sequence, and
explored its function. However, the interpretation of the data
demonstrating that overexpression of the HTE-1-binding protein
induces TIMP-1 expression (Figure 11) is made more difficult if
the HTE-1 sequence is not within the TIMP-1 gene.
We would very much welcome the authors’ input on these
matters.
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Sir,
The characterisation of the TIMP-1 gene was published in Wang
et al (1998). The TIMP-1 gene was cloned from PC-3 ML genomic
DNA. The Pst1–Xba1 fragment at the 50end of the Pst1 4.0-
kilobase TIMP-1 genomic clone was subcloned into plasmid PUC
19. This fragment was sequenced from both ends on opposite
strands with the Sequenase Virgin 2.0 sequencing system (US
Biochemical). Each strand was sequenced with both the Klenow
fragment and reverse transcriptase by standard dideoxy proce-
dures. Blast analysis of the 50 promoter region revealed a 97%
*Correspondence: Dr IM Clark; E-mail: i.clark@uea.ac.uk
*Correspondence: Dr ME Stearns; E-mail: Stearnsm1@aol.com
British Journal of Cancer (2003) 89, 1812–1813
& 2003 Cancer Research UK All rights reserved 0007– 0920/03 $25.00
www.bjcancer.comhomology with Homo sapiens TIMP-1 promoter region (chromo-
some X genomic contig, NT 011568). Blast analysis of the coding
region revealed a 97% homology with human TIMP-1 (Docherty
et al, 1985) and 96% homology with the coding region of the E. coli
TIMP-1.
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